Heated chemo during surgery may boost ovarian cancer survival
NCT ID NCT03772028
First seen Apr 10, 2026 · Last updated Apr 28, 2026 · Updated 2 times
Summary
This study tests whether adding heated chemotherapy directly into the abdomen during surgery helps people with stage III ovarian cancer live longer. About 538 participants are randomly assigned to standard surgery alone or surgery plus the heated chemo. The main goal is to see if the extra treatment improves overall survival and delays cancer return.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alice Bjoernlund-Larsen
Uppsala, Sweden
-
Amsterdam UMC
Amsterdam, Netherlands
-
Antoni van leeuwenhoek
Amsterdam, North Holland, 1066CX, Netherlands
-
CHRU Strasbourg
Strasbourg, France
-
CHU Lille
Lille, France
-
CHU Lyon
Lyon, France
-
CHU de Besancon
Besançon, France
-
Catharina Hospital
Eindhoven, Netherlands
-
Centre Leon Berard, Lyon
Lyon, France
-
City of Hope
Duarte, California, 91010, United States
-
Erasmus MC
Rotterdam, Netherlands
-
Fondazione Policlinico A Gemelli IRCCS
Roma, Italy
-
Institut Bergonié
Bordeaux, France
-
Institut Curie Paris
Paris, France
-
Institut de Cancerologie de l'Ouest, ICO Nantes)
Nantes, France
-
Institut du Cancer Montpellier
Montpellier, France
-
Leiden University Medical Center (LUMC)
Leiden, Netherlands
-
MSKCC New York
New York, New York, 10065, United States
-
Maastricht UMC+
Maastricht, Netherlands
-
Mater Misericordiae University Hospital, Dublin
Dublin, Ireland
-
Medisch Spectrum Twente
Enschede, Netherlands
-
Oncopole, Institute Universitaire du Cancer de Toulouse (IUCT Toulouse)
Toulouse, France
-
Policlinico Sant'Orsola, Bologna
Bologna, Italy
-
Radboud MC
Nijmegen, Netherlands
-
Rigshospitalet Copenhagen
Copenhagen, Denmark
-
UMCG
Groningen, Netherlands
-
UMCU
Utrecht, Netherlands
-
o Institut Bergonié, Bordeaux
Bordeaux, France
Conditions
Explore the condition pages connected to this study.